Federal Data Hub › HRSA 340B · JSON
Thomas D. Boyer Liver Institute's Hepatitis C Treatment Program · 340B ID STD85724
ParticipatingSTD
Arizona Board of Regents on Behalf of the University of Arizona Department of Medicine is a STD enrolled in the federal 340B Drug Pricing Program in Tucson, AZ. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 28 contract-pharmacy arrangement(s) (15 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| CURANT HEALTH FLORIDA, LLC | ST PETERSBURG, FL | 2020-04-01 | 2024-07-01 | 1936 |
| CURANT HEALTH FLORIDA, LLC | ST PETERSBURG, FL | 2024-10-01 | — | 1936 |
| CURANT HEALTH GEORGIA LLC | SMYRNA, GA | 2020-04-01 | 2024-07-01 | 1937 |
| CURANT HEALTH GEORGIA LLC | SMYRNA, GA | 2024-10-01 | — | 1937 |
| CYSTIC FIBROSIS SERVICES, LLC | FRISCO, TX | 2020-04-01 | 2024-07-01 | 110069 |
| CYSTIC FIBROSIS SERVICES, LLC | FRISCO, TX | 2024-10-01 | — | 110069 |
| OPTUM FRONTIER THERAPIES II, LLC | LAS VEGAS, NV | 2024-10-01 | — | 76984 |
| OPTUM FRONTIER THERAPIES II, LLC | LAS VEGAS, NV | 2020-10-01 | 2024-07-01 | 76984 |
| OPTUM PHARMACY 701, LLC | MESA, AZ | 2025-01-01 | — | 137427 |
| OPTUM PHARMACY 702, LLC | JEFFERSONVILLE, IN | 2024-10-01 | — | 90281 |
| OPTUM PHARMACY 702, LLC | JEFFERSONVILLE, IN | 2020-10-01 | 2024-07-01 | 90281 |
| OPTUM PHARMACY 801, INC. | PHOENIX, AZ | 2024-10-01 | — | 119478 |
| OPTUM PHARMACY 801, INC. | PHOENIX, AZ | 2020-10-01 | 2024-07-01 | 119478 |
| OPTUMRX | OVERLAND PARK, KS | 2024-10-01 | — | 62851 |
| OPTUMRX | OVERLAND PARK, KS | 2020-10-01 | 2024-07-01 | 62851 |
| PRIME THERAPEUTICS SPECIALTY PHARMACY LL | ORLANDO, FL | 2020-04-01 | 2024-07-01 | 39182 |
| PRIME THERAPEUTICS SPECIALTY PHARMACY LL | ORLANDO, FL | 2024-10-01 | — | 39182 |
| WALGREEN ARIZONA DRUG CO. | TOLLESON, AZ | 2025-07-01 | — | 130489 |
| WALGREEN ARIZONA DRUG CO. | TUCSON, AZ | 2020-04-01 | 2024-07-01 | 111426 |
| WALGREEN ARIZONA DRUG CO. | TUCSON, AZ | 2024-10-01 | — | 111426 |
| WALGREENS SPECIALTY PHARMACY, LLC | CANTON, MI | 2020-04-01 | 2024-07-01 | 4981 |
| WALGREENS SPECIALTY PHARMACY, LLC | CANTON, MI | 2024-10-01 | — | 4981 |
| WALGREENS SPECIALTY PHARMACY, LLC | BEAVERTON, OR | 2020-04-01 | 2024-07-01 | 4982 |
| WALGREENS SPECIALTY PHARMACY, LLC | BEAVERTON, OR | 2024-10-01 | — | 4982 |
| WALGREENS SPECIALTY PHARMACY, LLC | PITTSBURGH, PA | 2020-04-01 | 2024-07-01 | 4953 |
| WALGREENS SPECIALTY PHARMACY, LLC | PITTSBURGH, PA | 2024-10-01 | — | 4953 |
| WALGREENS SPECIALTY PHARMACY, LLC | FRISCO, TX | 2020-04-01 | 2024-07-01 | 4980 |
| WALGREENS SPECIALTY PHARMACY, LLC | FRISCO, TX | 2024-10-01 | — | 4980 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.